Nurix Therapeutics, Inc. (NRIX)

NGM – Real Time Price. Currency in USD

25.10

-0.41 (-1.59%)

Market open: Oct 23, 2026, 3:02 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025 (Nov 2025)

2024 (Nov 2024)

2023 (Nov 2023)

2022 (Nov 2022)

Total Revenue

84M

55M

77M

39M

Cost of goods sold

-19M

-16M

-14M

-11M

Gross Profit

65M

38M

63M

28M

Operating expenses (excl. COGS)

-351M

-251M

-218M

-212M

Operating Income

-286M

-213M

-155M

-184M

Non-operating income, total

22M

20M

11M

Pretax income

-264M

-193M

-144M

-180M

Equity in earnings

Taxes

-760K

-270K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-264M

-194M

-144M

-180M

Discontinued operations

Net income

-264M

-194M

-144M

-180M

Dilution adjustment

Preferred dividends

Nurix Therapeutics, Inc. (NRIX)

Get all premium features to the best stock analysis tool

Finranks

Contact us

Follow us

Nurix Therapeutics, Inc. (NRIX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Nurix Therapeutics, Inc. (NRIX)

Get all premium features to the best stock analysis tool

Finranks

Contact us

Follow us

Nurix Therapeutics, Inc. (NRIX)

Income Statement (Annual)

Income Statement (Annual)